Results 241 to 250 of about 267,118 (262)

Hematologic malignancies burden in China compared with the United States 1990-2021 and projections to 2040. [PDF]

Discov Oncol
Zheng W, Qin R, Dong H, Xiong W, Zhou X, Liu M, Guan L.   +6 more
europepmc   +1 more source

The Research Advances of Aptamers in Hematologic Malignancies

Cancers, 2023
Currently, research for hematological malignancies is very intensive, with many breakthroughs. Among them, aptamer-based targeted therapies could be counted.
Jing Liu, Shuming Sun, Hongling Peng
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Minority groups underrepresented in hematologic cancer trials

Ca-A Cancer Journal for Clinicians, 2023
Mike Fillon
exaly  

When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities

Blood Reviews, 2021
Nathan A. Berger, Rong Xu, Quanqiu Wang
exaly  

Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer

Cancers, 2021
Henrik Frederiksen, Jacob Hjelmborg, Signe Bedsted Clemmensen   +2 more
exaly  

Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance

Journal of Infection and Chemotherapy, 2023
Ichiro Ieiri, Nobuaki Egashira, Takeshi Hirota   +2 more
exaly  

Chromosome changes in hematologic malignancies

Ca-A Cancer Journal for Clinicians, 1981
Richard A. Larson, Harvey M Golomb, J D Rowley   +2 more
exaly  

Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications

Annals of Oncology, 2013
I I Raad, J E Cortes, I I Raad
exaly